|
659 After
the High Court, where next with the Charter? The unprecedented
legal wrangling over the proposed new Charter is set to continue and
looks likely to be unresolved before the first meeting of the new Royal
Pharmaceutical Society Council next month ...more
659 High
Court judge awards costs against SOS campaign Following the
summary dismissal of the Save Our Society High Court action against the
Royal Pharmaceutical Society and 16 members of its Council, Mr Justice
Park has awarded costs against the SOS litigants ...more
659 Mixed
reaction to Council election victory of all SOS candidates Pharmacists
have been reacting this week to the election of all seven Save Our Society
campaign candidates to the Royal Pharmaceutical Society's Council ...more
660 Moss
offers face-to-face dispensing at three stores Patients at
three Moss Pharmacy stores are being offered a new, more personal prescription
dispensing service ...more
660 Positive
impact of modernisation project at London hospital A two-year
modernisation project at the pharmacy department of the Chelsea and Westminster
Hospital, London, is complete and data on the impact the project is having
on the delivery of pharmacy services are now being collected ...more
660 Asda
now joins National Pharmaceutical Association The National
Pharmaceutical Association has accepted an application from Asda for
membership ...more
660 Future
rosy, so says Rosie Pharmacy's future is rosy, health minister
Rosie Winterton told North Yorkshire Local Pharmaceutical Committee's
business forum ...more
661 Hospital
pharmacist shortages mean missed targets Seventy per cent
of hospital pharmacies report that targets have been missed and services
have been restricted because of continuing staff shortages, according
to the results of an annual recruitment survey. Almost a third of junior
pharmacy posts were either left vacant or filled by locums, say researchers
...more
661 Workforce
review to indicate reasons for leaving profession A national
workforce review is set to reveal how the make-up of the pharmacy profession
is changing and what it needs to do to meet the challenges of the future
...more
661 Delay
in introducing new community pharmacy contract is made official Pharmacy
negotiators have officially ruled out introducing the new contract in
October following their latest meeting on 18 May with health minister
Rosie Winterton ...more
661 New support programme for implementing NICE guidance The National
Institute for Clinical Excellence launched a new programme last week
to support the implementation of its guidance in the NHS ...more
662 Public ban
on smoking supported by British adults Just over half of British
adults are in favour of a ban on smoking in public places, according
to a new report from Mintel. This finding comes as researchers from Imperial
College, London, reveal that tobacco smoke in the workplace is responsible
for about 700 deaths each year in the UK ...more
662 Improved
pharmaceutical care promised for Scottish cancer patients All
patients with cancer in Scotland should receive a pharmaceutical care
plan in the future, a report examining cancer services in Scotland has
concluded ...more
662 Further evidence
that aspirin protects against breast cancer Regular use of
aspirin is associated with a reduced risk of breast cancer, according
to new research ...more
|
663 Dukoral,
a new cholera vaccine, licensed in the UK Last week a new
cholera vaccine was launched in the UK. Dukoral, manufactured by Chiron
Vaccines Evans, is active against disease caused by Vibrio cholerae serogroup
01, and is licensed for adults and children over two years who will be
visiting areas where the disease is endemic or epidemic ...more
663 Preclinical
vCJD: prevalence higher than expected Scientists last week
expressed concern at the number of patients who could be incubating variant
Creutzfeldt-Jakob disease and the risk of iatrogenic spread of the infection
...more
663 Infant infections
do not confer allergy protection Having an infectious disease
early in life does not protect against the development of atopic dermatitis,
despite previous research suggesting it does, according to a new study
...more
663 Type 2 diabetes
going undetected in many British children The number of children
in the UK with type 2 diabetes may be far greater than previously thought
...more
663 FDA rejects
OTC EHC Emergency hormonal contraception will not be available
from US pharmacies without prescription, the Food and Drug Administration
has announced ...more
663 Opioids for
non-cancer pain Recommendations for the appropriate use of
opioids for persistent non-cancer pain have been published online on
behalf of the Pain Society, the Royal College of Anaesthetists, the Royal
College of General Practitioners and the Royal College of Psychiatrists
...more
664 ABPI
encourages children's medicines data sharing Companies
that have submitted data on medicines use in children to the
US Food and Drug Administration are to be encouraged by the Association
of the British Pharmaceutical Industry to send the data to UK
regulators ...more
664 Graduate
shortages frustrate the pharmaceutical industry Shortages
of suitably qualified science graduates, including pharmacists, are worrying
pharmaceutical companies ...more
664 NICE and
ABPI agreement on data release Agreement has been reached
by the National Institute for Clinical Excellence and the Association
of the British Pharmaceutical Industry on what company data should be
made public during a NICE health technology appraisal ...more
664 ETP still
on target for 2007 Electronic prescription transfer will be
fully implemented in England by the end of 2007. This is despite a suggestion
at a recent computing conference by Gordon Hextall, chief operating officer
of the Department of Health's national programme for IT (NPfIT), that
only some progress would be made by 2007 ...more
664 Health bureaucracy
to be cut as quangos go Quangos funded by the Department of
Health are to be cut by half, leading to savings of £500m within
three years. Health Secretary John Reid told the House of Commons on
20 May that 21 of the 42 bodies would be abolished or merged ...more
|
The
Pharmaceutical Journal